Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
Pred 634 dňami
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
Pred 900 dňami
FTSE 100 Advances Again
U.K. stocks are moving higher on Friday as investors continue to cheer the recent tariff agreement between U.S. and China, and news about a positive progress in talks between the EU bloc and U.S. for lowering the tariffs from earlier proposed levels.
RTTNews
|
Pred 1 h 34 min
Sensex, Nifty End Modestly Lower In Cautious Trade
Indian shares ended modestly lower on Friday but logged strong gains for the week, fueled by easing trade and geopolitical tensions.
RTTNews
|
Pred 1 h 56 min
CAC 40 Advances On Easing Trade Tensions
French stocks are up in positive territory on Friday, extending gains from the previous session, amid easing fears of a trade war.
Following announcements of U.S.-UK pact, and U.S.-China deal, reports about a positive progress in the EU bloc's discussions with the U.S. for considerable tariff reductions have bolstered investor sentiment.
RTTNews
|
Pred 2 h 2 min
DAX Up 0.8%, Looks Set To End Week On Strong Note
German stocks are up firmly in positive territory on Friday, amid easing trade tensions following the U.S.-China deal earlier in the week, and recent reports about a positive progress in the EU bloc's discussions with the U.S. for tariff reductions.
RTTNews
|
Pred 2 h 21 min
Antipodean Currencies Recovers Amid U.S.-China Trade Deal Optimism
The Antipodean currencies such as the Australia and the New Zealand recovered from recent lows against their major currencies in the Asian session on Friday, amid improved global trade optimism.
RTTNews
|
Pred 2 h 30 min
European Shares Edge Higher In Cautious Trade
European stocks traded higher on Friday as a slew of weak U.S. economic data suggested the Federal Reserve may have more leeway to cut interest rates later this year.
RTTNews
|
Pred 3 h 10 min
